{"id":"W3190957947","doi":"10.1177/13524585211035740","title":"Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ocrelizumab; Multiple sclerosis; Internal medicine; Clinical trial; Population; Relapsing remitting; Magnetic resonance imaging; Disease; Lesion; Oncology; Surgery; Radiology; Immunology; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.004219464,0.001130202,0.003182389,0.0007359272,0.001644689,0.0007803064,0.0004222374,0.00031716,0.0004046625],"category_scores_gemma":[0.02993684,0.0008684039,0.002953087,0.0007978621,0.0002374015,0.0004128828,0.0002960606,0.0008618237,0.00006170801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001620184,"about_ca_system_score_gemma":0.001540498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005644791,"about_ca_topic_score_gemma":0.00007016534,"domain_scores_codex":[0.990175,0.002088599,0.002354321,0.001517803,0.001798524,0.002065723],"domain_scores_gemma":[0.9860417,0.007959946,0.0007290131,0.001217917,0.001922038,0.002129384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.812179,0.00324762,0.007233998,0.0000742064,0.001885217,0.0001763797,0.00171703,0.0003792181,0.1503605,5.303199e-7,0.0009149768,0.0218313],"study_design_scores_gemma":[0.8951763,0.005621093,0.07417179,0.002515817,0.0008125811,0.00009660068,0.0005759438,0.008993263,0.007566619,0.000008187115,0.003573869,0.0008879172],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667231,0.008659123,0.003331475,0.005172175,0.001185684,0.01439142,0.0002591318,0.0002241551,0.00005370925],"genre_scores_gemma":[0.9590877,0.007334169,0.02093383,0.0008240483,0.001878791,0.00872077,0.0000536136,0.0002592229,0.0009078524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1427939,"threshold_uncertainty_score":0.999655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1405478466227287,"score_gpt":0.3381254336079222,"score_spread":0.1975775869851935,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}